92
Views
17
CrossRef citations to date
0
Altmetric
Original Research

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α

, , , , &
Pages 1663-1669 | Published online: 20 Sep 2019

References

  • Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001;2:986–991. doi:10.1093/embo-reports/kve23011713189
  • Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21. doi:10.1038/nrg360624296535
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159. doi:10.1038/nrg252119188922
  • Terashima M, Tange S, Ishimura A, et al. MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines. J Biol Chem. 2017;292:82–99. doi:10.1074/jbc.M116.75095027852821
  • Rajpathak SN, Vellarikkal SK, Patowary A, et al. Human 45, X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of Turner syndrome. PLoS One. 2014;9:e1000762014. doi:10.1371/journal.pone.0100076
  • Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–166. doi:10.1016/j.canlet.2013.06.01323791884
  • Black DM, Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2016;374:254–262. doi:10.1056/NEJMcp151372426789873
  • Gennari L, Rotatori S, Bianciardi S, et al. Treatment needs and current options for postmenopausal osteoporosis. Expert Opin Pharmacother. 2016;17:1141–1152. doi:10.1080/14656566.2016.117614727055223
  • Hassan MQ, Tye CE, Stein GS, et al. Non-coding RNAs: epigenetic regulators of bone development and homeostasis. Bone. 2015;81:746–756. doi:10.1016/j.bone.2015.05.02626039869
  • Zhang L, Kang W, Lu X, et al. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway. Cell Cycle. 2018;17:1886–1900. doi:10.1080/15384101.2018.150257430200804
  • Han Y, Chen M, Wang A, et al. STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway. Biochem Biophys Res Commun. 2018;32516.
  • Zhang Z, Zhou C, Chang Y, et al. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Letters. 2016;376(1):62–73. doi:10.1016/j.canlet.2016.03.02227012187
  • Zha L, He L, Liang Y, et al. TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. Biomed Pharmacother. 2018;102:369–374. doi:10.1016/j.biopha.2018.03.08029571022
  • Zheng SX, Vrindts Y, Lopez M, et al. Increase in cytokine production (IL-1β, IL-6, TNF-α but not IFN-γ, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas. 1997;26:63–71.9032749
  • Wu H, Liu J, Li W, et al. LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway. Biochem Biophys Res Commun. 2016;471:240–246. doi:10.1016/j.bbrc.2016.01.11726806307
  • Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155–170. doi:10.1016/j.jsbmb.2013.09.00824176761
  • Maeda SS, Lazaretti-Castro M. An overview on the treatment of postmenopausal osteoporosis. Arq Bras Endocrinol Metabol. 2014;58:162–171.24830593
  • Haro H, Crawford HC, Fingleton B, et al. Matrix metalloproteinase-7–dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J Clin Invest. 2000;105(2):143–150. doi:10.1172/JCI709110642592
  • Fu Y, Zhang P, Nan H, et al. LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer. Gene. 2019;704:91–96. doi:10.1016/j.gene.2019.04.01930965130